Observational Study
Copyright ©The Author(s) 2021.
World J Gastroenterol. Aug 28, 2021; 27(32): 5448-5459
Published online Aug 28, 2021. doi: 10.3748/wjg.v27.i32.5448
Table 2 No significant difference was found in univariate analysis when comparing patients stratified by outcome
Variables
Recovered, n = 13
Dead, n = 9
P value
Age in yr165 (61-78)71 (62-82)0.63
Sex (F)26 (46%)1 (11%)0.17
ACT/APT25 (38%)3 (33%)0.99
D-dimer15 N (2 N-9 N)5 N (3 N-54 N)0.92
PT (INR)11 (0.9-1.3)1.1 (1-1.5)0.48
aPTT (INR)10.9 (0.8-1.1)1 (0.9-1.3)0.4
Platelets (× 109/L)1271 (226-325)232 (68-278)0.11
1Express in median (Interquartile range).
2Express in number of subjects (percentage).
F: Female; ACT: Anticoagulant therapy; APT: Antiplatelets therapy; PT: Prothrombin time; INR: International normalized ratio; aPPT: Activated partial thromboplastin time; N: Normal value.
  • Citation: Norsa L, Bonaffini PA, Caldato M, Bonifacio C, Sonzogni A, Indriolo A, Valle C, Furfaro F, Bonanomi A, Franco PN, Gori M, Smania V, Scaramella L, Forzenigo L, Vecchi M, Solbiati M, Costantino G, Danese S, D'Antiga L, Sironi S, Elli L. Intestinal ischemic manifestations of SARS-CoV-2: Results from the ABDOCOVID multicentre study. World J Gastroenterol 2021; 27(32): 5448-5459
  • URL: https://www.wjgnet.com/1007-9327/full/v27/i32/5448.htm
  • DOI: https://dx.doi.org/10.3748/wjg.v27.i32.5448